epigallocatechin gallate has been researched along with Airflow Obstruction, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kodidhela, LD; Lakshmi, SP; Reddy, AT; Varadacharyulu, NC | 1 |
1 other study(ies) available for epigallocatechin gallate and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Epigallocatechin gallate diminishes cigarette smoke-induced oxidative stress, lipid peroxidation, and inflammation in human bronchial epithelial cells.
Topics: Aldehydes; Alveolar Epithelial Cells; Anti-Inflammatory Agents; Antioxidants; Bronchi; Catechin; Cell Line; Cigarette Smoking; Epithelial Cells; Humans; Inflammation; Lipid Peroxidation; NF-kappa B; Oxidation-Reduction; Oxidative Stress; Pulmonary Alveoli; Pulmonary Disease, Chronic Obstructive; Reactive Oxygen Species; Signal Transduction; Smoke; Smoking | 2020 |